WEKO3
アイテム
Clinical Evaluation of Immune Response in Patients with Cancer
http://hdl.handle.net/10069/15613
http://hdl.handle.net/10069/15613f578bed8-806a-47e7-88b1-2bb222677bb9
名前 / ファイル | ライセンス | アクション |
---|---|---|
acta24_01_05_t.pdf (384.5 kB)
|
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2008-03-10 | |||||
タイトル | ||||||
タイトル | Clinical Evaluation of Immune Response in Patients with Cancer | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | departmental bulletin paper | |||||
著者 |
Tomita, Masao
× Tomita, Masao× Koga, Yasunori× Shibata, Koichiro× Matsumoto, Kazuhisa× Onizuka, Toshio× Sakoda, Koichiro× Maeda, Takami× Hamasuna, Shigehito× Wake, Norio× Ichinose, Yukito |
|||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 91968 | |||||
姓名 | 富田, 正雄 | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 91969 | |||||
姓名 | 古賀, 保範 | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 91970 | |||||
姓名 | 柴田, 紘一郎 | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 91971 | |||||
姓名 | 松本, 和久 | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 91972 | |||||
姓名 | 鬼塚, 敏男 | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 91973 | |||||
姓名 | 迫田, 耕一朗 | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 91974 | |||||
姓名 | 前田, 隆美 | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Immune response was clinically evaluated in 25 patients with carcinoma compared with 26 of non cancer patients by means of lymphocyte transformation against PHA which was shown as stimulation index. In patients with cancer, stimulation index showed apparently as low as an average of 38 compared with 82 of non-cancer patients. Furthermore, the level of stimulation index was a corresponding correlation to age in which low activation was presented in the elderly. According to diseased organs, the weak response of stimulation index against PHA were observed in patients with the carcinoma of the esophagus and the lung. The response of skin test for PPD, PHA, SK-SD and candida were inhibited in patients with advanced cancer of stage III and IV compared with that of stage I and II. These responses were also suppressed in postoperative course until at least 6 months after surgery. From these results, it was noted that operative procedures provoked the induced weakness against host defense immunologically. However, it was certified that the use of immunopotentiator faciliated the activity of immune response during postoperative period for the patients with no severely advanced lung cancer of stage I and II despite of little effects for patients with advanced lung cancer of stage III and IV. It was concluded that immune response of patients with cancer was inhibited by advancing carcinoma and by operative procedures but the use of immunopotentiator was beneficial to promote the host defense during postoperative period. | |||||
書誌情報 |
Acta medica Nagasakiensia 巻 24, 号 1-4, p. 32-39, 発行日 1979-10-25 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00016055 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AA00508430 | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
sortkey | ||||||
値 | P00032-P00039 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Acta medica Nagasakiensia. 1979, 24(1-4), p.32-39 |